Vandana Khungar, Sammy Saab  Clinical Gastroenterology and Hepatology 

Slides:



Advertisements
Similar presentations
Management of ascites in patients with cirrhosis Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study  Elliot B. Tapper, Brian Halbert,
Nitsan Maharshak, Scott E. Plevy 
Effect of Renal Impairment on Mortality of Patients With Cirrhosis and Spontaneous Bacterial Peritonitis  Tsung–Hsing Hung, Chen–Chi Tsai, Yu–Hsi Hsieh,
Pichamol Jirapinyo, Christopher C. Thompson 
Proton Pump Inhibitors for Gastroduodenal Damage Related to Nonsteroidal Anti- inflammatory Drugs or Aspirin: Twelve Important Questions for Clinical Practice 
Coordinating Care in Patients With Cirrhosis
Shou–Jiang Tang, Feriyl Bhaijee 
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Celiac Disease and Persistent Symptoms
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Phillip S. Ge, MD, Bruce A. Runyon, MD 
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites  Georgios N. Kalambokis, Athanasia.
Georg Elias, Nabil Toubia  Clinical Gastroenterology and Hepatology 
Does Karnofsky Performance Status of Patients With Cirrhosis on the Transplant Waitlist Meet the Eyeball Test?  Elliot B. Tapper, MD  Clinical Gastroenterology.
Definition, Pathogenesis, and Management of That Cursed Dyspepsia
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression  Gati A. Goel, Abhishek Deshpande,
Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C  Pamela S. Belperio, Elizabeth.
Impact of Adherence to Concomitant Gastroprotective Therapy on Nonsteroidal-Related Gastroduodenal Ulcer Complications  Jay L. Goldstein, Kimberly B.
Jessica L. Mellinger, Michael L. Volk 
Activity-Based Costing and Management in a Hospital-Based GI Unit
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Endoscopic Therapy for Barrett's Esophagus
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
Rawad Mounzer, Shahid M. Malik, John Nasr, Bahar Madani, Michael E
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Novel Endoscopic Therapeutics for Early Gastric Cancer
Mild Enteropathy Celiac Disease: A Wolf in Sheep's Clothing?
Abnormal Liver Tests and Fatty Liver on Ultrasound
William D. Leslie  Clinical Gastroenterology and Hepatology 
New Models of Gastroenterology Practice
Ramesh Kumar, Masiullah, Pintu Kumar Singh 
Issue Highlights Clinical Gastroenterology and Hepatology
Endoscopic Ultrasound–Guided Fine-Needle Aspiration of Ascites
David H. Bruining, William J. Sandborn 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Kamal V. Patel, Rishi M. Goel, Terry Wong 
Patient-Reported Outcomes of Cirrhosis
Anil T. George, Raman V. Nair  Clinical Gastroenterology and Hepatology 
Tamir Ben–Menachem, Jason A. Dominitz 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Volume 147, Issue 4, Pages (October 2014)
Thrombocytopenia With Abnormal Liver Function Tests
Immune Dysfunction and Infections in Patients With Cirrhosis
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Issue Highlights Clinical Gastroenterology and Hepatology
Hematochezia From Metastasis of Hepatocellular Carcinoma to Colon in a Patient Who Underwent Liver Transplantation  Ruhail Kohli, Andrei S. Purysko, Binu.
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal.
Volume 139, Issue 6, Pages e1 (December 2010)
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Erick Alayo, Bashar Attar, Benjamin Go 
Black and White Liver Clinical Gastroenterology and Hepatology
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
The Role of Psychosocial Care in Adapting to Health Care Reform
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Presentation transcript:

Cirrhosis With Refractory Ascites: Serial Large Volume Paracentesis, TIPS, or Transplantation?  Vandana Khungar, Sammy Saab  Clinical Gastroenterology and Hepatology  Volume 9, Issue 11, Pages 931-935 (November 2011) DOI: 10.1016/j.cgh.2011.04.028 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Suggested approach to the cirrhotic patient with ascites not responsive to diuretics. GI, gastrointestinal; NSAID, nonsteroidal anti-inflammatory drug; OLT, orthotopic liver transplant; SBP, spontaneous bacterial peritonitis. †Lack of response defined as mean weight loss <0.8 kg over 4 days and urinary sodium output less than sodium intake on intensive diuretic therapy (spironolactone 400 mg by mouth daily and furosemide 160 mg by mouth daily) for at least 1 week and on a sodium restricted diet of <90 mmol/L per day or 5.2 g of salt per day. ‡Refractory ascites defined by the International Ascites Club is either: (1) diuretic resistant ascites—ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of a lack of response to dietary sodium restriction and intensive diuretic treatment; or (2) diuretic-intractable ascites—ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage. Clinical Gastroenterology and Hepatology 2011 9, 931-935DOI: (10.1016/j.cgh.2011.04.028) Copyright © 2011 AGA Institute Terms and Conditions